Clinical and genetic features of Hungarian achromatopsia patients

Balázs Varsányi, Bernd Wissinger, Susanne Kohl, Katja Koeppen, A. Farkas

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: To describe the clinical features and molecular genetic findings in a collection of Hungarian achromatopsia patients. Methods: Twelve patients with congenital achromatopsia from nine Hungarian families were analyzed in this study. The patients underwent standard ophthalmological examination including detailed full-field electroretinography and color vision testing. In two patients, dark adaptation and spectral luminosity tests were also performed. PCR/RFLP analysis and DNA sequencing was applied for mutation screening of CNGA3 and CNGB3. Heterologous minigene expression was used to evaluate transcript splicing of a new intronic mutation in CNGB3. Results: Mutations in CNGA3 were present in four families and mutations in CNGB3 in the remaining five families, including mutations known from Western European patient samples and two new CNGB3 mutations: c.112C>T/Gln38X and c.1663-5T>G. Heterologous expression in COS7 cells shows that the latter induces a splicing defect through the activation of a cryptic splice site 4 bases upstream of the genuine splice site. The patients presented with a clinical picture typical for congenital achromatopsia and there was no significant difference in the phenotype of subjects with either CNGA3 or CNGB3 mutations based on standard ophthalmological examination. However, we assume residual cone function in a subject homozygous for the Phe547Leu mutation in CNGA3 based on prior detailed psychophysical testing (i.e., dark adaptation and spectral luminosity). Conclusions: Mutations in CNGA3 and CNGB3 account for achromatopsia in Hungarian patients including known mutations and a few new CNGB3 mutations. While standard ophthalmological examination revealed a phenotype of complete achromatopsia, we show that thorough psychophysical testing can help to identify subjects with some minute cone function.

Original languageEnglish
Pages (from-to)996-1001
Number of pages6
JournalMolecular Vision
Volume11
Publication statusPublished - Nov 17 2005

Fingerprint

Color Vision Defects
Mutation
Dark Adaptation
Phenotype
Electroretinography
Color Vision
RNA Splice Sites
DNA Sequence Analysis
Restriction Fragment Length Polymorphisms
Molecular Biology

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Varsányi, B., Wissinger, B., Kohl, S., Koeppen, K., & Farkas, A. (2005). Clinical and genetic features of Hungarian achromatopsia patients. Molecular Vision, 11, 996-1001.

Clinical and genetic features of Hungarian achromatopsia patients. / Varsányi, Balázs; Wissinger, Bernd; Kohl, Susanne; Koeppen, Katja; Farkas, A.

In: Molecular Vision, Vol. 11, 17.11.2005, p. 996-1001.

Research output: Contribution to journalArticle

Varsányi, B, Wissinger, B, Kohl, S, Koeppen, K & Farkas, A 2005, 'Clinical and genetic features of Hungarian achromatopsia patients', Molecular Vision, vol. 11, pp. 996-1001.
Varsányi B, Wissinger B, Kohl S, Koeppen K, Farkas A. Clinical and genetic features of Hungarian achromatopsia patients. Molecular Vision. 2005 Nov 17;11:996-1001.
Varsányi, Balázs ; Wissinger, Bernd ; Kohl, Susanne ; Koeppen, Katja ; Farkas, A. / Clinical and genetic features of Hungarian achromatopsia patients. In: Molecular Vision. 2005 ; Vol. 11. pp. 996-1001.
@article{b97ad569394b47bf9b06c8618efdb1ea,
title = "Clinical and genetic features of Hungarian achromatopsia patients",
abstract = "Purpose: To describe the clinical features and molecular genetic findings in a collection of Hungarian achromatopsia patients. Methods: Twelve patients with congenital achromatopsia from nine Hungarian families were analyzed in this study. The patients underwent standard ophthalmological examination including detailed full-field electroretinography and color vision testing. In two patients, dark adaptation and spectral luminosity tests were also performed. PCR/RFLP analysis and DNA sequencing was applied for mutation screening of CNGA3 and CNGB3. Heterologous minigene expression was used to evaluate transcript splicing of a new intronic mutation in CNGB3. Results: Mutations in CNGA3 were present in four families and mutations in CNGB3 in the remaining five families, including mutations known from Western European patient samples and two new CNGB3 mutations: c.112C>T/Gln38X and c.1663-5T>G. Heterologous expression in COS7 cells shows that the latter induces a splicing defect through the activation of a cryptic splice site 4 bases upstream of the genuine splice site. The patients presented with a clinical picture typical for congenital achromatopsia and there was no significant difference in the phenotype of subjects with either CNGA3 or CNGB3 mutations based on standard ophthalmological examination. However, we assume residual cone function in a subject homozygous for the Phe547Leu mutation in CNGA3 based on prior detailed psychophysical testing (i.e., dark adaptation and spectral luminosity). Conclusions: Mutations in CNGA3 and CNGB3 account for achromatopsia in Hungarian patients including known mutations and a few new CNGB3 mutations. While standard ophthalmological examination revealed a phenotype of complete achromatopsia, we show that thorough psychophysical testing can help to identify subjects with some minute cone function.",
author = "Bal{\'a}zs Vars{\'a}nyi and Bernd Wissinger and Susanne Kohl and Katja Koeppen and A. Farkas",
year = "2005",
month = "11",
day = "17",
language = "English",
volume = "11",
pages = "996--1001",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Clinical and genetic features of Hungarian achromatopsia patients

AU - Varsányi, Balázs

AU - Wissinger, Bernd

AU - Kohl, Susanne

AU - Koeppen, Katja

AU - Farkas, A.

PY - 2005/11/17

Y1 - 2005/11/17

N2 - Purpose: To describe the clinical features and molecular genetic findings in a collection of Hungarian achromatopsia patients. Methods: Twelve patients with congenital achromatopsia from nine Hungarian families were analyzed in this study. The patients underwent standard ophthalmological examination including detailed full-field electroretinography and color vision testing. In two patients, dark adaptation and spectral luminosity tests were also performed. PCR/RFLP analysis and DNA sequencing was applied for mutation screening of CNGA3 and CNGB3. Heterologous minigene expression was used to evaluate transcript splicing of a new intronic mutation in CNGB3. Results: Mutations in CNGA3 were present in four families and mutations in CNGB3 in the remaining five families, including mutations known from Western European patient samples and two new CNGB3 mutations: c.112C>T/Gln38X and c.1663-5T>G. Heterologous expression in COS7 cells shows that the latter induces a splicing defect through the activation of a cryptic splice site 4 bases upstream of the genuine splice site. The patients presented with a clinical picture typical for congenital achromatopsia and there was no significant difference in the phenotype of subjects with either CNGA3 or CNGB3 mutations based on standard ophthalmological examination. However, we assume residual cone function in a subject homozygous for the Phe547Leu mutation in CNGA3 based on prior detailed psychophysical testing (i.e., dark adaptation and spectral luminosity). Conclusions: Mutations in CNGA3 and CNGB3 account for achromatopsia in Hungarian patients including known mutations and a few new CNGB3 mutations. While standard ophthalmological examination revealed a phenotype of complete achromatopsia, we show that thorough psychophysical testing can help to identify subjects with some minute cone function.

AB - Purpose: To describe the clinical features and molecular genetic findings in a collection of Hungarian achromatopsia patients. Methods: Twelve patients with congenital achromatopsia from nine Hungarian families were analyzed in this study. The patients underwent standard ophthalmological examination including detailed full-field electroretinography and color vision testing. In two patients, dark adaptation and spectral luminosity tests were also performed. PCR/RFLP analysis and DNA sequencing was applied for mutation screening of CNGA3 and CNGB3. Heterologous minigene expression was used to evaluate transcript splicing of a new intronic mutation in CNGB3. Results: Mutations in CNGA3 were present in four families and mutations in CNGB3 in the remaining five families, including mutations known from Western European patient samples and two new CNGB3 mutations: c.112C>T/Gln38X and c.1663-5T>G. Heterologous expression in COS7 cells shows that the latter induces a splicing defect through the activation of a cryptic splice site 4 bases upstream of the genuine splice site. The patients presented with a clinical picture typical for congenital achromatopsia and there was no significant difference in the phenotype of subjects with either CNGA3 or CNGB3 mutations based on standard ophthalmological examination. However, we assume residual cone function in a subject homozygous for the Phe547Leu mutation in CNGA3 based on prior detailed psychophysical testing (i.e., dark adaptation and spectral luminosity). Conclusions: Mutations in CNGA3 and CNGB3 account for achromatopsia in Hungarian patients including known mutations and a few new CNGB3 mutations. While standard ophthalmological examination revealed a phenotype of complete achromatopsia, we show that thorough psychophysical testing can help to identify subjects with some minute cone function.

UR - http://www.scopus.com/inward/record.url?scp=28344433688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344433688&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 996

EP - 1001

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -